Skip to content

Clinical trials

Terminated Autistic Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Status: Terminated Country / region: United States Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20092
20104
20113
20123
20133
20142
20153
20172
20183
20192
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Massachusetts General Hospital2
Seaside Therapeutics, Inc.2
Stanford University2
University of Arkansas2
Coronado Biosciences, Inc.1
Emory University1
Forest Laboratories1
Gonzalez-Heydrich, Joseph, M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder35
Autism Spectrum Disorder20
Child Development Disorders, Pervasive5
Asperger Syndrome4
Attention Deficit Disorder with Hyperactivity2
Cerebral Palsy2
Bipolar Disorder1
Brain Diseases1
Down Syndrome1
Mental Disorders1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.